Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 1
1(33.3%)
3Total
N/A(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04320355Not ApplicableCompleted

Exploring the Effects of Soft Tissue Manual Therapy on Caesarean Section Scar

Role: collaborator

NCT02158832Not ApplicableWithdrawn

Acupuncture for Lymphedema Secondary to Breast Cancer Treatment

Role: collaborator

NCT00907062Phase 1Completed

Ginkgo Biloba for the Treatment of Vitiligo Vulgaris in Adolescents

Role: collaborator

All 3 trials loaded